Business Description
Taiwan Advance Bio-Pharmaceutical Inc
ISIN : TW0004186002
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.47 | |||||
Equity-to-Asset | 0.33 | |||||
Debt-to-Equity | 1.29 | |||||
Debt-to-EBITDA | 5.81 | |||||
Interest Coverage | 4.45 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 0.69 | |||||
Beneish M-Score | -2.76 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.5 | |||||
3-Year EPS without NRI Growth Rate | 53.5 | |||||
3-Year Book Growth Rate | -13.3 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 71.67 | |||||
9-Day RSI | 60.47 | |||||
14-Day RSI | 54.39 | |||||
6-1 Month Momentum % | 0.33 | |||||
12-1 Month Momentum % | -10.98 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.85 | |||||
Quick Ratio | 0.78 | |||||
Cash Ratio | 0.49 | |||||
Days Inventory | 72.47 | |||||
Days Sales Outstanding | 65.43 | |||||
Days Payable | 10.34 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 0.32 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 67.64 | |||||
Operating Margin % | 9.95 | |||||
Net Margin % | 6.32 | |||||
FCF Margin % | 9.02 | |||||
ROE % | 9.57 | |||||
ROA % | 2.98 | |||||
ROIC % | 4.63 | |||||
3-Year ROIIC % | 81.61 | |||||
ROC (Joel Greenblatt) % | 10.37 | |||||
ROCE % | 6.7 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 67.09 | |||||
PE Ratio without NRI | 58.23 | |||||
PS Ratio | 4.22 | |||||
PB Ratio | 6.26 | |||||
Price-to-Tangible-Book | 6.26 | |||||
Price-to-Free-Cash-Flow | 46.77 | |||||
Price-to-Operating-Cash-Flow | 39.26 | |||||
EV-to-EBIT | 56.15 | |||||
EV-to-EBITDA | 31.21 | |||||
EV-to-Revenue | 4.69 | |||||
EV-to-FCF | 50.61 | |||||
Price-to-Median-PS-Value | 0.55 | |||||
Price-to-Graham-Number | 4.03 | |||||
Earnings Yield (Greenblatt) % | 1.78 | |||||
FCF Yield % | 2.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Taiwan Advance Bio-Pharmaceutical Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 338.829 | ||
EPS (TTM) (NT$) | 0.237 | ||
Beta | 0.58 | ||
Volatility % | 28.2 | ||
14-Day RSI | 54.39 | ||
14-Day ATR (NT$) | 0.590819 | ||
20-Day SMA (NT$) | 15.4075 | ||
12-1 Month Momentum % | -10.98 | ||
52-Week Range (NT$) | 14 - 20.9 | ||
Shares Outstanding (Mil) | 90 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Taiwan Advance Bio-Pharmaceutical Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Taiwan Advance Bio-Pharmaceutical Inc Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Taiwan Advance Bio-Pharmaceutical Inc Frequently Asked Questions
What is Taiwan Advance Bio-Pharmaceutical Inc(ROCO:4186)'s stock price today?
When is next earnings date of Taiwan Advance Bio-Pharmaceutical Inc(ROCO:4186)?
Does Taiwan Advance Bio-Pharmaceutical Inc(ROCO:4186) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |